Nabriva Therapeutics AG ADR buy melinda
Start price
19.09.17
/
50%
?9.37
Target price
19.10.17
€11.73
Performance (%)
-36.18%
End price
19.10.17
€5.98
Summary
This prediction ended on 19.10.17 with a price of €5.98. Massive losses of -36.18% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Nabriva Therapeutics AG ADR | - | - | - | - |
iShares Core DAX® | 2.147% | 2.681% | 17.410% | 16.694% |
iShares Nasdaq 100 | -0.578% | -0.816% | 24.107% | 34.957% |
iShares Nikkei 225® | 0.635% | 3.079% | 16.921% | 11.023% |
iShares S&P 500 | 0.746% | 0.171% | 23.802% | 37.315% |
Comments by melinda for this prediction
In the thread Nabriva Therapeutics AG ADR diskutieren
Nabriva
DUBLIN - Die Aktien der Nabriva Therapeutics boomen heute Morgen , nachdem das Unternehmen experimentelle Antibiotikum für die in der Gemeinschaft (CABP) erworben bakterielle Pneumonie Behandlung hat die Bewertungskriterien erfüllt in einer Schlüsselphase III - Studie.
(Vom Mitglied beendet)
Stopped prediction by melinda for Nabriva Therapeutics AG ADR
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?2.54
14.03.19
14.03.19
€4.51
04.11.19
04.11.19
0.00%
04.11.19
04.11.19
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?5.99
19.10.17
19.10.17
€7.67
20.02.18
20.02.18
-17.17%
20.02.18
20.02.18
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?6.64
19.10.17
19.10.17
€8.50
20.02.18
20.02.18
-17.17%
20.02.18
20.02.18
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?8.75
11.05.17
11.05.17
€10.37
17.05.17
17.05.17
4.59%
17.05.17
17.05.17